Somanath Kundu: h-index, Total Citations, and Citation Map
Somanath Kundu's h-index is 13 (14 i10-index, 455+ total citations across 26+ publications) according to Google Scholar as of June 2026. Somanath Kundu is affiliated with SUNY Upstate Medical University.
Somanath Kundu is a researcher affiliated with SUNY Upstate Medical University, specializing in Tumor microenvironment, Immunotherapy, ECM proteins. Their work has been cited 455 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Somanath Kundu's Citation Metrics
Bibliometric impact based on 26 indexed publications.
- H-Index
- 13
- i10-Index
- 14
- Total Citations
- 455
- Citing Countries
- 36
As of June 2026.
Somanath Kundu has an h-index of 13 and 455 total citations across 26 publications, with research cited by institutions in 36 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Somanath Kundu's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin
201493
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
50 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher pioneered bile acid-based conjugate strategies for targeted breast cancer therapy, establishing a foundational framework for localized drug delivery and exploring broader gastrointestinal cancer mechanisms.
The researcher pioneered the design and mechanistic analysis of lithocholic acid amphiphiles for colon cancer therapy, establishing a foundational framework for bile acid-based anticancer agents.
The researcher identified fibulin-3 as a driver of pleural mesothelioma growth via PI3K/Akt signaling and extended this mechanism to glioblastoma immunosuppression.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Somanath Kundu's research
Somanath Kundu is a researcher in Tumor microenvironment, Immunotherapy and ECM proteins at SUNY Upstate Medical University. Their work has been cited 455 times across 26 publications (h-index 13), according to Google Scholar.
Their most-cited work, “Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin” (2014), has accumulated 93 citations. Other influential works include “Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin” (2014) with 93 citations and “Cross‐talk between bile acids and gastrointestinal tract for progression and development of cancer and its therapeutic implications” (2015) with 74 citations.
Citations of Somanath Kundu's research come primarily from China, United States and India, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
